関連する実験動画
Updated: Sep 10, 2025

05:39
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
560
侵襲性エペンジモーマ患者の生存パターンと死亡原因: 2000年から2019年の遡及コホート分析
Anas Elgenidy1, Khaled Saad2, Amir Aboelgheet2
1Department of Neurology, Faculty of Medicine, Cairo University, Cairo 12613, Egypt.
Medical sciences (Basel, Switzerland)
|August 22, 2025
まとめ
エペンジモマの生存率は高いが,小児患者の死亡リスクは最も高い. 脳血管疾患は がん以外の死因の1つであり,総合的なケアが必要であることを強調しています.
科学分野:
- 神経腫瘍学
- 流行病学
- 臨床的成果 研究
背景:
- 中枢神経系 (CNS) の原発性腫瘍である.
- 脳と脊髄の付細胞から発生します
- 中枢神経系腫瘍の3-6%を占める.
研究 の 目的:
- アメリカにおけるエペンジモマの生存パターンを分析するために
- エペンジモーマ患者の非癌死因を調査する.
主な方法:
- SEER 17のレジストリ (2000年−2019年) を利用した遡及的研究
- エペンジモマの発生率,生存率,死亡率の傾向の評価
- 癌以外の死因の分析
主要な成果:
- 3821人の患者で842人の死亡 (22%) が発生しました.
- 最も高い死亡率は,診断から1年以内に18歳未満の患者でした.
- 主要な死因は中枢神経系がん,脳血管疾患,肺炎,インフルエンザ,結血病でした.
- 1年,3年,5年の生存率はそれぞれ94%,88%,84%でした.
- 条件付き生存率は時間の経過とともに著しく改善しました.
結論:
- 小児患者 (18歳未満) の死亡率は最も高い.
- 脳血管疾患は癌以外の主な死因です.
- 診断後の生存期間が長くなるにつれて生存確率は増加する.
さらに関連する動画
関連する概念動画
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Comparing the Survival Analysis of Two or More Groups
285
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
285
Actuarial Approach
133
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
133
Kaplan-Meier Approach
260
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
260
Introduction To Survival Analysis
395
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
395

